HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...

Biomea Fusion (BMEA) announced the presentation of preclinical data from its investigational menin inhibitor icovamenib in combination with ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies ...

Transfer of funds through cheques has been a long-standing practice worldwide. Efficient clearance of interbank cheques is crucial for a quicker payment and settlement system. It cuts costs and ...

If AI is to become pervasive, as the model builders and datacenter builders who are investing enormous sums of money are ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress Annual Meeting, taking place from ...

- 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on top of standard ...

Therapeutics announced the presentation of new 4-year muscle function, muscle strength and biomarker endpoints from the PROPEL ...

Mineralys Therapeutics, Inc. stock jumped on promising lorundrostat hypertension data, sparking M&A buzz. Click for more on MLYS stock prospects.

Data derived from Freedman A, et al. Abstract #102. Presented at: American Heart Association’s Hypertension Scientific ...

Acushnet school officials can pick one or more of the following to receive town students: New Bedford, Fairhaven, ORR and Apponequet high schools.

Announced Transformative Recapitalization Plan to Strengthen the Balance Sheet and Inject Capital into the Business Continued Growth of the Business with July Ending Active Subscribers + 13.4% YoY Ach ...